Proteomic identification of human urinary biomarkers in diabetes mellitus type 2

Diabetes Technology and Therapeutics

Volumn 12, Issue 12, 2010, Pages 979-988

  Riaz, Samreen ^a,b   Alam, Saadia Shahzad ^c   Srai, Surjit Kaila ^a   Skinner, Vernon ^a   Riaz, Aasma ^d   Akhtar, M Waheed ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c Sheikh Zayed Hospital   (Pakistan)

^d UNIVERSITY OF THE PUNJAB   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ALPHA2 GLYCOPROTEIN; BIOLOGICAL MARKER; HAPTOGLOBIN; PREALBUMIN; PROTEIN; RETINOL BINDING PROTEIN 4; ULINASTATIN; UNCLASSIFIED DRUG; UVOMORULIN; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CHROMATOFOCUSING; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PAKISTAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; URINALYSIS;

ADULT; AGED; ALBUMINS; ALPHA-GLOBULINS; BIOLOGICAL MARKERS; CADHERINS; CARRIER PROTEINS; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLYCOPROTEINS; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PREALBUMIN; PROTEOMICS; RETINOL-BINDING PROTEINS, PLASMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78650118229     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0078     Document Type: Article

References (27)

1. Riaz S: Diabetes mellitus. Sci Res Essay 2009;4:367-373.
2. Thongboonkerd V: Urinary proteomics. Towards biomarker discovery, diagnosis and prognostics. Mol BioSyst 2008;4: 810-815.
3. Young M, Byung S, Nameok L, Sung M, Kyong S: Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006;29:2457-2461.
4. Anderson NG, Anderson NL, Tollaksen S: Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis. Clin Chem 1979;25:1199-1210.
5. Dihazi H, Mu G, Lindner S, Meyer M, Asid A, Oellerich M, Strutz F: Characterization of diabetic nephropathy by urinary proteomic analysis. Clin Chem 2007;53:1636-1645.
6. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y: Identification of urinary soluble E-cadherin as a novel bio-marker for diabetic nephropathy. Diabetes Metab Res Rev 2009;25:232-241.
7. Shinton N, Richardson RW, Williams JD: Diagnostic value of serum haptoglobin. J Clin Pathol 1965;18:114-116.
8. Stejskal D, Karṕis?ek M, Reutová H, Stejskal P, Kotolová H, Kollár P: Determination of serum zinc-alpha-2- glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008;41:313-316.
9. Fernández J, Cobián F, Méndez E: Measurement of protein HC (alpha 1 microglobulin) and protein HC-IgA complex in different body fluids. J Clin Pathol 1988;41:1176-1179.
10. Ando Y: Transthyretin: its miracle function and pathogene-sis [in Japanese]. Rinsho Byori 2009;57:228-235.
11. Rabbani N, Alam SS, Riaz S, Larkin J, Akhtar MW, Shafi T, Thornalley PJ: High dose thiamine therapy for people with type 2 diabetes and microalbuminuria: a randomised, double-blind, placebo-controlled study. Diabetologia 2009; 52:208-212.
12. Bradford MM: A rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
13. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680-685.
14. Betgovargez E, Simonian MH: Reproducibility and Dynamic Range Characteristics of the ProteomeLab PF 2D System Beckman Coulter Application. Information Bulletin A-1964A. Fullerton, CA: Beckman Coulter, 2003.
15. Barratt J, Topham P: Urine proteomics, the present and future of measuring urinary protein components in disease. CMAJ 2007;177:361-368.
16. Riaz S, Alam SS, Akhtar W: Proteomic identification of human serum biomarkers in diabetes mellitus type 2. J Pharm Biomed Anal 2010;51:1103-1107.
17. Butt A, Riaz S: Study of protein profiling of human urine in diabetic hypertensive nephropathy versus normal healthy controls. Diabetes Technol Ther 2010;12;379-386.
18. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 2004;27(Suppl 1):S79-S83.
19. Fabre J, Balant L, Dayer P, Fox H, Vernet A: The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982;21:730-738.
20. Rao PV, Lu X, Standley M, Pattee P, Girishie G, Dak-shinamurthy KV, Roberts CT JR, Nagalla SR: Proteomic identification of urinary biomarkers of diabetic nephropa-thy. Diabetes Care 2007;30:629-637.
21. Erratum in: Diabetes Care 2007;30:1330.
22. Hong C, Chia K, Ling S: Urinary protein excretion in Type 2 diabetes with complications. J Diabetes Complications 2000; 14:259-265.
23. Ruggenenti P, Fassi A, Ilieva AP: Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004;351:1941-1951.
24. Tepper B, Kim Y, Shete V, Shabrova E, Quadro L: Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem 2010;43:320-323.
25. Bondar O, Barnidge D, Klee E, Davis B, Klee G: LC-MS/MS quantification of zinc alpha 2 glycoprotein. Clin Chem 2007; 53:673-678.
26. Altland K, Benson M, Costello C, Ferlini A, Hazenberg B, Hund E, Kristen A, Linke R, Merlini G, Salvi F, Saraiva M, Singer F, Skinner M: Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 2007;28: 2053-2064.
27. Itoh Y, Enomoto H, Takagi K, Kawai T, Yamanaka T: Human alpha1-microglobulin in various hepatic disorders. Digestion 1983;27:75-80.